AAO-HNSF Clinical Practice Guideline Development
Public Comment – QI Opportunities for Potential Inclusion in Clinical Practice Guideline: Allergic Rhinitis
Tuesday, October 1 - Tuesday, October 15
A draft list of quality improvement (QI) opportunities for potential inclusion in the upcoming AAO-HNSF Clinical Practice Guideline: Allergic Rhinitis now available for public comment. The comment period will run from Tuesday, October 1 thru Tuesday, October 15. During this time, members of the public are encouraged to review the draft QI list and provide additional QI topics that should be considered by the guideline development group for prioritization in the space provided. The purpose of the comment period is to ensure that all pertinent stakeholders, including the public, have an opportunity to review the guideline's scope and potential QI topics to ensure that nothing is left out.
Please remember that this guideline is intended for all clinicians in any setting who are likely to diagnose and manage patients with Allergic Rhinitis. The target population is inclusive of both adults and children presenting with Allergic Rhinitis.
We ask that non-healthcare professionals specifically pay close attention to the potential QI topics list and include any additional topics which may be most relevant to members of the public.
To participate in the public comment, users are asked to complete a conflict of interest disclosure. Once Public reviewers have downloaded the document, they will be emailed a link to return to the site to enter their comments, after they have had an opportunity to review the document.
The guideline development panel will review all submitted comments. Please note that the guideline panel will not be providing responses to comments received. If necessary, individuals may be contacted for comment clarification.